Curie Oncology

Singapore 329563

2 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumors, Breast Cancer, Gastric Cancer, Head and Neck Cancer, Hepatocellular Carcinoma, Lung Cancer, Melanoma, Metastatic Breast Cancer, Metastatic Non-small Cell Lung Cancer, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer

Studies at this site

• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) — Recruiting now
• LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC — Recruiting now
• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
• A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma — Running, not enrolling
• Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer — Completed
• A Study of ZW191 in Participants With Solid Tumors — Running, not enrolling
• Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) — Running, not enrolling